These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
369 related items for PubMed ID: 22267712
1. Recurrent Guillain-Barre syndrome following vaccination. Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP, CISA Network. Clin Infect Dis; 2012 Mar; 54(6):800-4. PubMed ID: 22267712 [Abstract] [Full Text] [Related]
5. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses. Tokars JI, Lewis P, DeStefano F, Wise M, Viray M, Morgan O, Gargiullo P, Vellozzi C. Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672 [Abstract] [Full Text] [Related]
6. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009). Souayah N, Yacoub HA, Khan HM, Farhad K, Mehyar LS, Maybodi L, Menkes DL, Qureshi AI. J Clin Neuromuscul Dis; 2012 Dec; 14(2):66-71. PubMed ID: 23172385 [Abstract] [Full Text] [Related]
13. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, Upshur RE, Manuel DG, Moineddin R, Wilson K. Arch Intern Med; 2006 Nov 13; 166(20):2217-21. PubMed ID: 17101939 [Abstract] [Full Text] [Related]
14. Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010. Choe YJ, Cho H, Kim SN, Bae GR, Lee JK. Vaccine; 2011 Oct 13; 29(44):7727-32. PubMed ID: 21827815 [Abstract] [Full Text] [Related]
15. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database. Alcalde-Cabero E, Almazán-Isla J, García López FJ, Ara-Callizo JR, Avellanal F, Casasnovas C, Cemillán C, Cuadrado JI, Duarte J, Fernández-Pérez MD, Fernández Ó, Merino JA, Montero RG, Montero D, Pardo J, Rodríguez-Rivera FJ, Ruiz-Tovar M, de Pedro-Cuesta J, Spanish GBS Epidemiology Study Group. BMC Neurol; 2016 May 21; 16():75. PubMed ID: 27206524 [Abstract] [Full Text] [Related]
17. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, Stukel TA, Crowcroft NS, McGeer AJ, Zinman L, Deeks SL. Lancet Infect Dis; 2013 Sep 21; 13(9):769-76. PubMed ID: 23810252 [Abstract] [Full Text] [Related]
18. Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage. Iqbal S, Li R, Gargiullo P, Vellozzi C. Vaccine; 2015 Apr 21; 33(17):2045-9. PubMed ID: 25749247 [Abstract] [Full Text] [Related]
19. Analysis of data from the CDC/FDA vaccine adverse event reporting system (1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA. Souayah N, Yacoub HA, Khan HM, Farhad K, Maybodi L, Qureshi AI, Menkes DL. J Clin Neurosci; 2012 Aug 21; 19(8):1089-92. PubMed ID: 22705140 [Abstract] [Full Text] [Related]
20. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children. Esteghamati A, Gouya MM, Keshtkar AA, Mahoney F. Vaccine; 2008 Sep 15; 26(39):5058-61. PubMed ID: 18662736 [Abstract] [Full Text] [Related] Page: [Next] [New Search]